Equities

Aditxt Inc

ADTX:NAQ

Aditxt Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.3826
  • Today's Change-0.015 / -3.87%
  • Shares traded7.30m
  • 1 Year change-97.87%
  • Beta0.9899
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Aditxt Inc fell by 2.67m. Cash Flow from Financing totalled 15.92m or 2,467.48% of revenues. In addition the company used 18.58m for operations while cash used for investing totalled 14.41k.
Cash flow per share-39.19
Price/Cash flow per share--
Book value per share3.29
Tangible book value per share3.29
More ▼

Balance sheet in USDView more

Aditxt Inc has a Debt to Total Capital ratio of 50.84%.
Current ratio0.0733
Quick ratio0.0458
Total debt/total equity0.9992
Total debt/total capital0.5084
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.